Picard Medical, Inc. (PMI) intrinsic value & 10-year financials
Picard Medical, Inc. (PMI) has no Graham intrinsic value right now because the formula needs positive earnings. Over the last 3 fiscal years revenue grew 12.5% a year to $4.9M, with an average return on invested capital of 43.8%.
- Graham intrinsic value
- —
- Share price (Oct 17, 2026)
- $12.75
- Revenue (FY2025)
- $4.9M
- Revenue growth (3-yr CAGR)
- 12.5%
- ROIC (10-yr avg)
- 43.8%
- Free cash flow (FY2025)
- —
PMI 10-year financial history
| Fiscal year | Revenue | Net income | EPS (diluted) | Free cash flow | Operating margin | ROIC |
|---|---|---|---|---|---|---|
| FY2025 | $4.9M | -$27.0M | — | — | -268.4% | 56.2% |
| FY2024 | $4.4M | -$21.1M | — | — | -312.3% | 31.4% |
| FY2023 | — | — | — | — | — | — |
Source: annual 10-K filings on SEC EDGAR. Figures in USD.
Executive summary
Picard Medical, Inc. revenue growth over the past decade is N/A; insufficient history prevents a reliable 10-year CAGR calculation.
Picard Medical, Inc. has earned high returns on invested capital, averaging 43.8% ROIC over the available history. High ROIC is consistent with a durable franchise, but it is not by itself proof of an economic moat.
Picard Medical, Inc. capital allocation metrics are N/A for the decade; share count and net debt history are incomplete.
Benjamin Graham lens
Under Benjamin Graham's formula using SEC EDGAR fundamentals, Picard Medical, Inc. is modeled at 12.5% normalized earnings growth with a 5.1% bond-yield adjustment.